Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept
- PMID: 17127178
- DOI: 10.1016/j.nucmedbio.2006.08.005
Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept
Abstract
Introduction: Our objective was to develop a technique for quantifying the extent of atherosclerosis in the aorta by combining standard uptake values (SUVs) in the aortic wall with volumetric data provided by computed tomography (CT).
Methods: Eighteen patients who had both 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET) and contrast-enhanced CT of the chest and abdomen were selected. All had homogeneous diffuse FDG wall uptake in four segments of the aorta. We divided the patients into three groups according to their age and measured FDG uptake in all four segments of the aorta by calculating the mean SUV for each segment. On each axial CT image, region-of-interest tracings along the inner and outer wall contours of the aorta were generated. The inner surface area was subtracted from the outer surface area. The net area values for each segment were subsequently multiplied by slice thickness to calculate arterial wall volume. By multiplying SUV with wall volume, we were able to calculate the atherosclerotic burden (AB) for each segment of the aorta. We compared the aortic wall volumes, SUVs and AB values in each arterial segment for each age group.
Results: In each aortic wall segment, AB values, SUVs and wall volumes increased with age (P<.05).
Conclusion: AB can be used as an indicator of the extent of the atherosclerotic process in the aorta through the use of both metabolic and morphologic data provided by FDG-PET and CT, respectively. This may allow for the optimal screening, diagnosis and management of patients with this common and potentially lethal disorder.
Similar articles
-
Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.Ann Nucl Med. 2008 Jul;22(6):505-12. doi: 10.1007/s12149-008-0135-2. Epub 2008 Aug 1. Ann Nucl Med. 2008. PMID: 18670857
-
F-18 FDG PET/CT in the management of thyroid cancer.Clin Nucl Med. 2007 Sep;32(9):690-5. doi: 10.1097/RLU.0b013e318125037a. Clin Nucl Med. 2007. PMID: 17710020
-
Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT.Clin Nucl Med. 2007 Sep;32(9):729-31. doi: 10.1097/RLU.0b013e318123f7a6. Clin Nucl Med. 2007. PMID: 17710030
-
PET/CT for atherosclerotic plaque imaging.Q J Nucl Med Mol Imaging. 2006 Mar;50(1):53-60. Q J Nucl Med Mol Imaging. 2006. PMID: 16557204 Review.
-
PET features of aortic diseases.AJR Am J Roentgenol. 2010 Jul;195(1):229-33. doi: 10.2214/AJR.09.3952. AJR Am J Roentgenol. 2010. PMID: 20566821 Review.
Cited by
-
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.Mol Imaging Biol. 2011 Dec;13(6):1051-60. doi: 10.1007/s11307-010-0459-x. Mol Imaging Biol. 2011. PMID: 21161689 Review.
-
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.J Nucl Cardiol. 2012 Dec;19(6):1211-25. doi: 10.1007/s12350-012-9631-9. J Nucl Cardiol. 2012. PMID: 23073913 Free PMC article. Review.
-
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries.Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):562-9. doi: 10.1007/s00259-007-0528-9. Epub 2007 Oct 24. Eur J Nucl Med Mol Imaging. 2008. PMID: 17957367
-
Assessment of global cardiac uptake of radiolabeled iron oxide nanoparticles in apolipoprotein-E-deficient mice: implications for imaging cardiovascular inflammation.Mol Imaging Biol. 2014 Jun;16(3):330-9. doi: 10.1007/s11307-013-0709-9. Mol Imaging Biol. 2014. PMID: 24297372 Free PMC article.
-
Aortic and coronary atherosclerosis: a natural association?Int J Cardiovasc Imaging. 2009 Feb;25(2):219-22. doi: 10.1007/s10554-008-9389-y. Epub 2008 Nov 27. Int J Cardiovasc Imaging. 2009. PMID: 19037749 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical